Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP0113 Therapeutic CMV Vaccine in CMV-Seropositive Allogeneic HCT Recipients
KCT0000990Phase 3Active, not recruiting
- Sponsor
- Astellas Pharma
- Start
- Aug 2014
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of ASP0113 in cytomegalovirus disease (CMV), sponsored by Astellas Pharma. Started Aug 2014; status: active, not recruiting.
02
Drugs
ASP0113
03
Conditions
cytomegalovirus disease (CMV)
Beyond the preview
Go deeper on KCT0000990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000990.